p53 immunohistochemistry: A word of caution

Human Pathology

Volumn 25, Issue 5, 1994, Pages 435-437

  Battifora, Hector ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER GRADING; CARCINOGENESIS; EDITORIAL; GENE MUTATION; GROWTH REGULATION; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS;

HUMAN; IMMUNOHISTOCHEMISTRY; MUTATION; PROTEIN P53;

EID: 0028303865     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(94)90113-9     Document Type: Editorial

References (26)

1. Tumour suppressor genes: No room at the p53 inn
2. Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations
3. p53 Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer
4. p53 Mutations in human bladder cancer: Genotypic versus phenotypic patterns
5. Pancreatic adenocarcinomas frequently show p53 gene mutations
6. The correlation of p53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis
7. Mutations of the p53 gene do not occur in testis cancer
8. Mutant p53 product in patients with stage III cervical cancer
9. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection
10. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection
11. Mutant p53 expression in prostate carcinoma
12. p53 Oncogene mutations in human prostate cancer specimens
13. p53 Gene alterations in human prostate carcinoma
14. Microwave-based antigenic unmasking: A revolutionary new technique for routine immunohistochemistry
15. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds
16. p53 In tumour pathology: Can we trust immunocytochemistry?
17. p53 Immunostaining in the differentiation of reactive processes from malignancy in pleural biopsies
18. p53 And Kirstenras mutations in human mesothelioma cell lines
19. Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium
20. p53 Protein expression in breast cancer as related to histopathological characteristics and prognosis
21. p53 Mutations and histological type of invasive breast carcinoma
22. Relationship between p53 expression and other prognostic factors in human breast carcinoma. An immunohistochemical study
23. p53 Expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study
24. Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers
25. Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathologic data
26. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations